CoChat

Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort

Open access
Chemaitilly, Wassim, Li, Zhenghong, Krasin, Matthew J., Brooke, Russell J., Wilson, Carmen L., Green, Daniel M., Klosky, James L., Barnes, Nicole, Clark, Karen L., Farr, Jonathan B., Fernandez-Pineda, Israel, Bishop, Michael W., Metzger, Monika, Pui, Ching-Hon, Kaste, Sue C., Ness, Kirsten K., Srivastava, Deo Kumar, Robison, Leslie L., Hudson, Melissa M., Yasui, Yutaka, Sklar, Charles A. · 2017 · The Journal of Clinical Endocrinology & Metabolism
Cited by 216

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Context: Long-term follow-up data on premature ovarian insufficiency (POI) in childhood cancer survivors are limited. Objective: To describe the prevalence of POI, its risk factors, and associated long-term adverse health outcomes. Design: Cross-sectional. Setting: The St. Jude Lifetime Cohort Study, an established cohort in a tertiary care center. Patients: Nine hundred twenty-one participants (median age, 31.7 years) were evaluated at a median of 24.0 years after cancer diagnosis. Main Outcome Measure: POI was defined by persistent amenorrhea combined with a follicle-stimulating hormone level >30 IU/L before age 40. Multivariable Cox regression was used to study associations between demographic or treatment-related risk factors and POI. Multivariable logistic regression was used to study associations between POI and markers for cardiovascular disease, bone mineral density (BMD), and frailty. Exposure to alkylating agents was quantified using the validated cyclophosphamide equivalent dose (CED). Results: The prevalence of POI was 10.9%. Independent risk factors for POI included ovarian radiotherapy at any dose and CED ≥8000 mg/m2. Patients with a body mass index ≥30 kg/m2 at the time of the St. Jude Lifetime Cohort assessment were less likely to have a diagnosis of POI. Low BMD and frailty were independently associated with POI. Conclusion: High-dose alkylating agents and ovarian radiotherapy at any dose are associated with POI. Patients at the highest risk should be offered fertility preservation whenever feasible. POI contributes to poor general health outcomes in childhood cancer survivors; further studies are needed to investigate the role of sex hormone replacement in improving such outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2016-3723

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Chemaitilly, W., Li, Z., Krasin, M. J., Brooke, R. J., Wilson, C. L., Green, D. M., Klosky, J. L., Barnes, N., Clark, K. L., Farr, J. B., Fernandez-Pineda, I., Bishop, M. W., Metzger, M., Pui, C.-H., Kaste, S. C., Ness, K. K., Srivastava, D. K., Robison, L. L., Hudson, M. M., Yasui, Y., & Sklar, C. A.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2017-03-24
Volume
102
Issue
7
Pages
2242-2250
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2618696300
Cited by
216
References
6
FWCI
16.97
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.